Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is used
against HIV infections as a fixed-dose combination with another protease ...
The combination of lopinavir and ritonavir is used with other medications to treat
human immunodeficiency virus (HIV) infection. Lopinavir and ritonavir are in a ...
KALETRA<sup>®</sup> (lopinavir/ritonavir) is a prescription HIV-1 medicine that is used with
other HIV medicines to treat HIV-1 (Human Immunodeficiency Virus) infection in ...
Aug 29, 2007 ... Description, Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class
. It is marketed by Abbott as Kaletra, a co-formulation with a ...
Lopinavir/ritonavir (Kaletra, Aluvia) is a protease inhibitor drug available in tablet
and solution form. Lopinavir is marketed only with a boosting dose of ritonavir; ...
Jul 9, 2015 ... Lopinavir and ritonavir (Kaletra) HIV drug treatment side effects, drug interactions
, dosage, and pregnancy safety information.
Medscape - HIV dosing for Kaletra (lopinavir/ritonavir), frequency-based adverse
effects, comprehensive interactions, contraindications, pregnancy & lactation ...
KALETRA is a co-formulation of lopinavir and ritonavir. Lopinavir is an inhibitor of
the HIV-1 protease. As co-formulated in KALETRA, ritonavir inhibits the ...
KALETRA (lopinavir/ritonavir) is a co-formulation of lopinavir and ritonavir.
Lopinavir is an inhibitor of the HIV-1 protease. As co-formulated in KALETRA,
Lopinavir and ritonavir combination is used in the treatment of the infection
caused by the human immunodeficiency virus (HIV). HIV is the virus responsible